NCT04936919 is a NA clinical trial of BroadBand Light in Pigmented Lesions, sponsored by Sciton.

Who is sponsoring NCT04936919?

NCT04936919 is sponsored by Sciton.

What drugs are being tested in NCT04936919?

Interventions in NCT04936919: BroadBand Light.

What condition does NCT04936919 study?

NCT04936919 studies Pigmented Lesions.

Is NCT04936919 still recruiting?

NCT04936919 is currently completed. Last updated 19 April 2023.

Last reviewed 2023-04-19 · How we verify

NCT04936919

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Pilot Evaluation of Smart vs HERO Broadband Light Treatment for Pigmented Skin Lesions

Completed NA Last updated 19 April 2023

What this trial tests

NA trial testing BroadBand Light in Pigmented Lesions in 12 participants. Completed in 15 March 2022.

Timeline

28 May 2021

Primary endpoint
25 February 2022

15 March 2022

Quick facts

Lead sponsor	Sciton
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	12
Start date	28 May 2021
Primary completion	25 February 2022
Estimated completion	15 March 2022
Sites	1 location across United States

Drugs / interventions tested

BroadBand Light

Conditions studied

Pigmented Lesions — all drugs for Pigmented Lesions →

Sponsor

Sciton

Who can join

18 and older, any sex, with Pigmented Lesions. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of the study is to investigate the effects of Intense Pulsed Broad Band Light for treatment of pigmented lesions

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Pigmented Lesions

Currently open trials in the same condition.

NCT06655129 — Intense Pulsed Light (IPL) Medical Device as Treatment for Patient Suffering From Skin Disorder · NA · recruiting
NCT06557434 — AV-23-001 AVAVA MIRIA Pilot Study · NA · active not recruiting

Other Sciton trials

Trials by the same sponsor.

NCT06363240 — Evaluation of Broadband Light Treatment for Solar Lentigines · NA · completed
NCT06389071 — Laser Treatment for Lichen Sclerosus · NA · recruiting
NCT05750901 — Evaluation of Fractional Ablative Laser Treatment for Skin Conditions · NA · recruiting
NCT05662592 — Evaluation of Broadband Light Treatment Protocol for Pigmented Skin Lesions - A Comparative Study · NA · completed
NCT05750914 — Evaluation of Broadband Light Treatment for Pigmented Skin Lesions · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04936919 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Sciton
Last refreshed: 19 April 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04936919.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing